Endpoints News 8 dic 2025 #ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?
BioPharma Dive 8 dic 2025 Terns drug shows potential to challenge Novartis’ blockbuster leukemia treatment
BioPharma Dive 26 nov 2025 Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
Endpoints News 25 nov 2025 Novartis was the sole bidder in $12B deal to buy Avidity #Avidity Biosciences #buy Avidity
Endpoints News 24 nov 2025 #ASH25: Kelonia’s first in vivo CAR-T data; Lilly, J&J and Novartis spell out Phase 3 wins #American Society #wins Late-breaking
Lonza News 7 oct 2025 Biotechnology Market Therapeutic Innovations & Forecast Report 2025-2033 Featuring Lonza, Amgen, Syngenta, Biocon, Biogen, F. Hoffmann-La Roche, Novartis, Novo Nordisk A/S, Pfizer, and Seagen - ResearchAndMarkets.com - Business Wire #Therapeutic Innovations #Forecast Report
Roche Media 26 sept 2025 Roche, Novartis underline U.S. plans after Trump pharma tariff announcement - Reuters #Novartis underline #Trump pharma